This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
General Mills (GIS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
General Mills (GIS) closed at $76.15 in the latest trading session, marking a +0.32% move from the prior day.
McCormick (MKC) Lowers FY22 Guidance on Preliminary Q3 Results
by Zacks Equity Research
McCormick (MKC) lowers fiscal 2022 view, considering third-quarter preliminary results; moderation of consumption trends, supply-chain costs, currency headwinds and impacts from a divestiture.
Can Favorable Trends Aid Diageo (DEO) Despite Cost Woes?
by Zacks Equity Research
Diageo (DEO) looks poised to retain momentum on a sustained recovery in the on-trade channel, strong consumer demand in the off-trade channel and market share gains.
GIS vs. NSRGY: Which Stock Is the Better Value Option?
by Zacks Equity Research
GIS vs. NSRGY: Which Stock Is the Better Value Option?
Newell Brands (NWL) Lowers View on Soft Demand & Inflation
by Zacks Equity Research
Newell Brands (NWL) trims its 2022 guidance and lowers its Q3 view to reflect the impacts of inflation, tough macro environment, soft demand and unfavorable currency.
Lamb Weston's (LW) Latest Move Accelerates Expansion Efforts
by Zacks Equity Research
Lamb Weston (LW) plans to construct a new manufacturing unit in Mar del Plata, Buenos Aires. Management expects to conclude the facility's construction by the middle of 2024.
Church & Dwight's (CHD) Buyout of Hero to Bolster Portfolio
by Zacks Equity Research
Church & Dwight (CHD) inks a deal to buy the Hero Mighty Patch brand (or Hero) and other acne treatment products. The deal is anticipated to close in the fourth quarter of 2022.
General Mills (GIS) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
General Mills (GIS) closed the most recent trading day at $75.30, moving -1.85% from the previous trading session.
B&G Foods (BGS) Looks Troubled: High Input Cost a Key Concern
by Zacks Equity Research
B&G Foods (BGS) expects to keep seeing significant cost inflation for inputs, such as ingredients, packaging, labor and transportation.
Kimberly-Clark's (KMB) Cost-Cutting Efforts Aid Amid High Costs
by Zacks Equity Research
Kimberly-Clark (KMB) is focused on undertaking relevant cost-cutting initiatives and pricing actions to counter inflation. Focus on three key strategic growth pillars is noteworthy.
Here's Why Keurig Dr Pepper (KDP) is Marching Ahead of the Industry
by Zacks Equity Research
Keurig Dr Pepper (KDP) benefits from continued strength in the Packaged Beverages segment and robust pricing actions. However, rising inflation remains concerning.
Take the Zacks Approach to Beat the Market: Walmart (WMT), Ulta Beauty (ULTA), UniCredit (UNCFF) in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our accomplishments from last week.
Archer Daniels (ADM) Banks On Solid Nutrition Unit, High Demand
by Zacks Equity Research
Archer Daniels (ADM) is likely to continue gaining from healthy demand, strength in the Nutrition unit and other growth efforts, including its portfolio expansion and strategic partnerships.
Hormel Foods (HRL) Q3 Earnings Lag Estimates, Revenues Up Y/Y
by Zacks Equity Research
Hormel Foods' (HRL) third-quarter top and bottom lines increase year over year. While management raises its sales view for fiscal 2022, it lowers its earnings per share guidance.
Campbell (CPB) Earnings Meet, Sales Beat Estimates in Q4
by Zacks Equity Research
Campbell's (CPB) Q4 results reflect higher net sales on growth across all segments and better supply-chain performance. Management issues upbeat fiscal 2022 view.
Campbell Soup (CPB) Q4 Earnings Meet Estimates
by Zacks Equity Research
Campbell (CPB) delivered earnings and revenue surprises of 0% and 0.61%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Pilgrim's Pride (PPC) Up More than 20% in 6 Months: Here's Why
by Zacks Equity Research
Pilgrim's Pride's (PPC) focus on key customers is a pathway for refining its portfolio and creating competitive advantages. Also, its efforts to expand in new regions bode well.
Medifast (MED) Down More Than 20% in 3 Months on Cost Woes
by Zacks Equity Research
Medifast (MED) has been seeing high SG&A expenses and escalated raw material costs. The company expects short-term margin pressure in 2022 due to inflation and continued investments.
Is Invesco Dynamic Food & Beverage ETF (PBJ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PBJ
Pricing, Demand Up International Flavors (IFF) Despite Cost Woes
by Zacks Equity Research
Pricing actions, productivity initiatives, and investment in growth and acquisitions remain key drivers for International Flavors (IFF) despite inflationary cost pressures.
Kraft Heinz (KHC) Gains on Pricing Efforts Amid Rising Costs
by Zacks Equity Research
Kraft Heinz (KHC) benefits from solid pricing initiatives. It is committed to accelerating profit and enhancing shareholders' long-term value.
Colgate (CL) Banks On Brand Strength Amid Cost Headwinds
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
General Mills (GIS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
General Mills (GIS) closed the most recent trading day at $77.22, moving +1.18% from the previous trading session.
Tyson Foods (TSN) Benefits From Capacity Expansion, High Demand
by Zacks Equity Research
Tyson Foods (TSN) is undertaking several operational and supply chain efficiency programs to place itself better in the long run. Also, its retail business is a key driver.
Altria (MO) Unveils Dividend Hike: What Else Should You Know?
by Zacks Equity Research
Altria Group (MO) declares a dividend hike of 4.4%, taking its quarterly dividend to 94 cents per share. The company is focused on boosting shareholders' returns.